Yash Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.51 Cr
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.96 Cr
- Revenue Growth 225.06%
- Profit Growth -71.27%
- Ebitda -998.12%
- Net Worth 24.62%
- Total Assets 804.12%
About Yash Lifesciences
Yash Lifesciences Private Limited (YLPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 17 August 2020 (Four years and six months 10 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.51 Cr.
The company currently has active open charges totaling ₹1.96 Cr.
Sangeeta Jain, Yash Jain, and Rajesh Jain serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24246DL2020PTC368111
- Company No.
368111
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Yash Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sangeeta Jain  | Director | 22-Apr-2024 | Current |
| Yash Jain | Director | 17-Aug-2020 | Current |
| Rajesh Jain | Director | 17-Aug-2020 | Current |
Financial Performance of Yash Lifesciences.
Yash Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 225.06% increase. The company also saw a substantial fall in profitability, with a 71.27% decrease in profit. The company's net worth Soared by an impressive increase of 24.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yash Lifesciences?
In 2023, Yash Lifesciences had a public holding of 33.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Yash Herbal International Private LimitedSangeeta Jain and Yash Jain are mutual person
Solario Tuff'n Glass Private LimitedRajesh Jain is a mutual person
Evuar Herbal Private LimitedYash Jain is a mutual person
- Solario Glass Ventures Private Limited
Rajesh Jain is a mutual person
- Jain International Welfare Organisation
Rajesh Jain is a mutual person
Charges (Loans)
₹1.96 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 1.96 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Aug 2022 | Others | ₹1.96 Cr | Open |
How Many Employees Work at Yash Lifesciences?
Yash Lifesciences has a workforce of 4 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yash Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yash Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
